Literature DB >> 25526311

Dysfunctional HIV-specific CD8+ T cell proliferation is associated with increased caspase-8 activity and mediated by necroptosis.

Gaurav D Gaiha1, Kevin J McKim1, Matthew Woods1, Thomas Pertel2, Janine Rohrbach1, Natasha Barteneva3, Christopher R Chin4, Dongfang Liu5, Damien Z Soghoian1, Kevin Cesa1, Shannon Wilton1, Michael T Waring6, Adam Chicoine1, Travis Doering7, E John Wherry8, Daniel E Kaufmann9, Mathias Lichterfeld10, Abraham L Brass4, Bruce D Walker11.   

Abstract

Decreased HIV-specific CD8(+) T cell proliferation is a hallmark of chronic infection, but the mechanisms of decline are unclear. We analyzed gene expression profiles from antigen-stimulated HIV-specific CD8(+) T cells from patients with controlled and uncontrolled infection and identified caspase-8 as a correlate of dysfunctional CD8(+) T cell proliferation. Caspase-8 activity was upregulated in HIV-specific CD8(+) T cells from progressors and correlated positively with disease progression and programmed cell death-1 (PD-1) expression, but negatively with proliferation. In addition, progressor cells displayed a decreased ability to upregulate membrane-associated caspase-8 activity and increased necrotic cell death following antigenic stimulation, implicating the programmed cell death pathway necroptosis. In vitro necroptosis blockade rescued HIV-specific CD8(+) T cell proliferation in progressors, as did silencing of necroptosis mediator RIPK3. Thus, chronic stimulation leading to upregulated caspase-8 activity contributes to dysfunctional HIV-specific CD8(+) T cell proliferation through activation of necroptosis and increased cell death.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25526311      PMCID: PMC4312487          DOI: 10.1016/j.immuni.2014.12.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  64 in total

1.  High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control.

Authors:  Zaza M Ndhlovu; Lori B Chibnik; Jacqueline Proudfoot; Seanna Vine; Ashley McMullen; Kevin Cesa; Filippos Porichis; R Brad Jones; Donna Marie Alvino; Meghan G Hart; Eleni Stampouloglou; Alicja Piechocka-Trocha; Carl Kadie; Florencia Pereyra; David Heckerman; Philip L De Jager; Bruce D Walker; Daniel E Kaufmann
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

2.  Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2.

Authors:  N Regamey; T Harr; M Battegay; P Erb
Journal:  AIDS Res Hum Retroviruses       Date:  1999-06-10       Impact factor: 2.205

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Death effector domain DEDa, a self-cleaved product of caspase-8/Mch5, translocates to the nucleus by binding to ERK1/2 and upregulates procaspase-8 expression via a p53-dependent mechanism.

Authors:  Zhan Yao; Shanshan Duan; Dezhi Hou; Klaus Heese; Mian Wu
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

5.  Activation of caspases-8 and -10 by FLIP(L).

Authors:  Kelly M Boatright; Cristina Deis; Jean-Bernard Denault; Daniel P Sutherlin; Guy S Salvesen
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

6.  HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL.

Authors:  Constantinos Petrovas; Yvonne M Mueller; Ioannis D Dimitriou; Paul M Bojczuk; Karam C Mounzer; James Witek; John D Altman; Peter D Katsikis
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

7.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

8.  Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.

Authors:  J E Arends; A I M Hoepelman; N M Nanlohy; F J P Höppener; K R Hirsch; J G Park; D van Baarle
Journal:  Apoptosis       Date:  2011-09       Impact factor: 4.677

9.  A human memory T cell subset with stem cell-like properties.

Authors:  Luca Gattinoni; Enrico Lugli; Yun Ji; Zoltan Pos; Chrystal M Paulos; Máire F Quigley; Jorge R Almeida; Emma Gostick; Zhiya Yu; Carmine Carpenito; Ena Wang; Daniel C Douek; David A Price; Carl H June; Francesco M Marincola; Mario Roederer; Nicholas P Restifo
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440

10.  Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells.

Authors:  A Alam; L Y Cohen; S Aouad; R P Sékaly
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  40 in total

1.  Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.

Authors:  Chaohuan Guo; Rong Fu; Mianjing Zhou; Shuang Wang; Yuefang Huang; Haoqiang Hu; Jijun Zhao; Felicia Gaskin; Niansheng Yang; Shu Man Fu
Journal:  J Autoimmun       Date:  2019-05-24       Impact factor: 7.094

Review 2.  Indoctrinating T cells to attack pathogens through homeschooling.

Authors:  Caitlin S Parello; Eric S Huseby
Journal:  Trends Immunol       Date:  2015-05-12       Impact factor: 16.687

3.  Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.

Authors:  David Shasha; Dan Karel; Olivia Angiuli; Adam Greenblatt; Musie Ghebremichael; Xu Yu; Filippos Porichis; Bruce D Walker
Journal:  J Leukoc Biol       Date:  2016-07-12       Impact factor: 4.962

4.  Influenza A Virus Infection Triggers Pyroptosis and Apoptosis of Respiratory Epithelial Cells through the Type I Interferon Signaling Pathway in a Mutually Exclusive Manner.

Authors:  SangJoon Lee; Mikako Hirohama; Masayuki Noguchi; Kyosuke Nagata; Atsushi Kawaguchi
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

Review 5.  Initiation and execution mechanisms of necroptosis: an overview.

Authors:  Sasker Grootjans; Tom Vanden Berghe; Peter Vandenabeele
Journal:  Cell Death Differ       Date:  2017-05-12       Impact factor: 15.828

6.  Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection.

Authors:  Christian Deo T Deguit; Michelle Hough; Rebecca Hoh; Melissa Krone; Christopher D Pilcher; Jeffrey N Martin; Steven G Deeks; Joseph M McCune; Peter W Hunt; Rachel L Rutishauser
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.731

Review 7.  Necroptosis in development, inflammation and disease.

Authors:  Ricardo Weinlich; Andrew Oberst; Helen M Beere; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

Review 8.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

9.  Metabolic pathway activation distinguishes transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.

Authors:  Fatema Z Chowdhury; Zhengyu Ouyang; Maria Buzon; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

Review 10.  Necroptosis: Mechanisms and Relevance to Disease.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Francis Ka-Ming Chan; Guido Kroemer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.